Entrada Therapeutics, Inc. · NASDAQ:TRDA
Janus Henderson Group PLC reported a 5.60% stake in Entrada Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Janus Henderson Group PLC reported a 5.60% stake in Entrada Therapeutics, Inc., 2,080,367 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 2,080,367
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 5.60% | 2,080,367 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.00% | 1,884,826 |
Source
Related
- Entrada Therapeutics, Inc.
- Janus Henderson Group PLC
- Entrada Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · May 14, 2025
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026